Herti 440mg Injection

Product Description

Herti 440mg Injection contains Trastuzumab as its active ingredient and is indicated for treating HER2-positive breast cancer. In patients with HER2-positive tumors, breast cancer cells often exhibit high levels of HER2 proteins, which promote rapid tumor growth by acting as signals for the cancerous cells. This medication is also effective for treating metastatic gastric cancer that presents elevated HER2 levels.

HER2-positive breast cancer is known for its aggressive nature. The targeted therapy provided by Herti works by specifically targeting the proteins responsible for the growth, development, and spread of the cancer. It is crucial to use effective birth control during treatment and for at least seven months after the last dose.

Herti 440mg Injection is not recommended for individuals under 18, those with severe respiratory issues, or patients requiring oxygen therapy. It™s important to inform your doctor if you have a history of heart problems, experience breathlessness, or have previously undergone other cancer treatments. Be sure to discuss all medications you are taking, including supplements and herbal products, with your healthcare provider before starting this treatment.